SPONSOR
University of Leipzig
Total Trials
4
Recruiting
4
Phases
Phase 3
Conditions studied: Peripheral Vascular DiseasesKidney DiseasesEnterostomyCardiac AmyloidosisHeart Failure - NYHA II - IV
University of Leipzig is a clinical research sponsor with 4 registered studies on ClinicalTrials.gov, of which 4 are actively recruiting participants. Research covers conditions including Peripheral Vascular Diseases, Kidney Diseases, Enterostomy, Cardiac Amyloidosis.
The trial portfolio spans Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — University of Leipzig
How many clinical trials has University of Leipzig sponsored?
ClinicalMetric currently tracks 4 clinical trials sponsored by University of Leipzig, of which 4 are actively recruiting participants. These trials cover conditions including Peripheral Vascular Diseases, Kidney Diseases, Enterostomy. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does University of Leipzig research focus on?
University of Leipzig clinical trials span Peripheral Vascular Diseases, Kidney Diseases, Enterostomy, Cardiac Amyloidosis, Heart Failure - NYHA II - IV. The research pipeline includes Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a University of Leipzig clinical trial?
To participate in a University of Leipzig trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all University of Leipzig trials with current recruitment status updated daily.
Clinical Trials by University of Leipzig
NCT06656988 Phase 3
Recruiting
A Contrast Medium Sparing Strategy Using Automated CO2 Injection During PVI for Prevention of Major Adverse Kidney Events (MAKE)
Peripheral Vascular Diseases
NCT03469609
Recruiting
Mucous Fistula Refeeding Reduces the Time From Enterostomy Closure to Full Enteral Feeds ("MUC-FIRE" Trial)
Enterostomy
NCT06129656
Recruiting
Cardiac Amyloidosis Registry of University Hospital Leipzig
Cardiac Amyloidosis
NCT06656832
Recruiting
Peripheral Drivers of Heart Failure Progression - The Prospective PEDAL-HF Study
Heart Failure - NYHA II - IV
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology